Suppressing glucagon secretion: Glucagon is a hormone that raises blood sugar
When considering Tirzepatide for weight management, some of the potential benefits include: Weight Reduction: Patients have reported significant weight loss over time
Optimal dosages for most patients may range between 1.0 to 2.4 mg once weekly , but this is subject to change per your providers discretion
Patients should be instructed to seek immediate medical attention for red-flag symptoms including intractable vomiting, severe dehydration, acute abdominal pain, gastrointestinal bleeding, or recurrent hypoglycemia, which may indicate surgical complications requiring urgent evaluation by the bariatric surgery team
Founder Cassandra Debenham, ACNP-BC, left the COVID ICU in 2021 to create a more meaningful healthcare experience, one where providers have time to truly understand each patients unique needs, goals, and health concerns
The FDA resolved the tirzepatide shortage in October 2024 and ended compounding discretion in early 2025 (503A: February 18, 503B: March 19)